Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA334721
Max Phase: Preclinical
Molecular Formula: C38H48N8O7S
Molecular Weight: 760.92
Molecule Type: Protein
Associated Items:
ID: ALA334721
Max Phase: Preclinical
Molecular Formula: C38H48N8O7S
Molecular Weight: 760.92
Molecule Type: Protein
Associated Items:
Synonyms (1): MEN-10627
Synonyms from Alternative Forms(1):
Canonical SMILES: CSCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CNC(=O)C[C@H](NC1=O)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N[C@@H](Cc1ccccc1)C(=O)N2
Standard InChI: InChI=1S/C38H48N8O7S/c1-21(2)15-27-34(49)41-26(13-14-54-3)33(48)45-30-18-32(47)40-20-31(38(53)42-27)46-35(50)28(16-22-9-5-4-6-10-22)43-36(51)29(44-37(30)52)17-23-19-39-25-12-8-7-11-24(23)25/h4-12,19,21,26-31,39H,13-18,20H2,1-3H3,(H,40,47)(H,41,49)(H,42,53)(H,43,51)(H,44,52)(H,45,48)(H,46,50)/t26-,27-,28-,29-,30-,31-/m0/s1
Standard InChI Key: CFDNUNSOUUFTQO-HPMAGDRPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 760.92 | Molecular Weight (Monoisotopic): 760.3367 | AlogP: 0.19 | #Rotatable Bonds: 9 |
Polar Surface Area: 219.49 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 8 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 10.30 | CX Basic pKa: | CX LogP: 0.34 | CX LogD: 0.34 |
Aromatic Rings: 3 | Heavy Atoms: 54 | QED Weighted: 0.15 | Np Likeness Score: 0.56 |
1. Lombardi A, D'Agostino B, Nastri F, D'Andrea LD, Filippelli A, Falciani M, Rossi F, Pavone V.. (1998) A novel super-potent neurokinin A receptor antagonist containing dehydroalanine., 8 (10): [PMID:9871726] [10.1016/s0960-894x(98)00178-4] |
2. Horwell DC, Howson W, Naylor D, Wilems HM. (1995) The design of polar -turn dipeptide mimetics, 5 (14): [10.1016/0960-894X(95)00254-Q] |
3. Lombardi A, D'Agostino B, Filippelli A, Pedone C, Matera MG, Falciani M, De Rosa M, Rossi F, Pavone V.. (1998) Neuronorm is a potent and water soluble neurokinin A receptor antagonist., 8 (13): [PMID:9873425] [10.1016/s0960-894x(98)00282-0] |
4. Horwell DC, Naylor D, Willems HM. (1997) 2,3-Substituted 2-azanorbornanes as polar -turn mimetics, 7 (1): [10.1016/S0960-894X(96)00570-7] |
5. Giannotti D, Perrotta E, Di Bugno C, Nannicini R, Harmat NJ, Giolitti A, Patacchini R, Renzetti AR, Rotondaro L, Giuliani S, Altamura M, Maggi CA.. (2000) Discovery of potent cyclic pseudopeptide human tachykinin NK-2 receptor antagonists., 43 (22): [PMID:11063600] [10.1021/jm0010217] |
Source(1):